{"abstract": "Mylan\u2019s price increases for the allergy treatment device highlight a common tactic in the industry: raising prices just before a generic competitor reaches the market.", "web_url": "https://www.nytimes.com/2016/08/25/business/mylan-raised-epipens-price-before-the-expected-arrival-of-a-generic.html", "snippet": "Mylan\u2019s price increases for the allergy treatment device highlight a common tactic in the industry: raising prices just before a generic competitor reaches the market.", "lead_paragraph": "In 2012, the company behind the EpiPen settled a lawsuit by agreeing to allow a generic competitor into the market in 2015, potentially cutting into a big part of its business.", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2016/08/25/business/25EPPEN/25EPPEN-articleLarge.jpg", "height": 399, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2016/08/25/business/25EPPEN/25EPPEN-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 399}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2016/08/25/business/25EPPEN/25EPPEN-jumbo.jpg", "height": 681, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2016/08/25/business/25EPPEN/25EPPEN-superJumbo.jpg", "height": 1363, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2016/08/25/business/25EPPEN/25EPPEN-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2016/08/25/business/25EPPEN/25EPPEN-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2016/08/25/business/25EPPEN/25EPPEN-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Mylan Raised EpiPen\u2019s Price Before the Expected Arrival of a Generic", "kicker": null, "content_kicker": null, "print_headline": "Last Shot at EpiPen Profits Ends in a Mylan Monopoly", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "persons", "value": "Pollack, Andrew", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Mylan Inc", "rank": 2, "major": "N"}, {"name": "subject", "value": "Prices (Fares, Fees and Rates)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Generic Brands and Products", "rank": 4, "major": "N"}, {"name": "subject", "value": "Medical Devices", "rank": 5, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 6, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 7, "major": "N"}, {"name": "organizations", "value": "Sanofi SA", "rank": 8, "major": "N"}, {"name": "subject", "value": "Epinephrine (Drug)", "rank": 9, "major": "N"}, {"name": "subject", "value": "ALLERGIES", "rank": 10, "major": "N"}], "pub_date": "2016-08-25T00:21:05+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/aee18876-71ab-5d93-850b-a6f63adba8f2", "word_count": 1146, "uri": "nyt://article/aee18876-71ab-5d93-850b-a6f63adba8f2"}